Charles River Laboratories Intl. Inc vs iShares Global Clean Energy ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while iShares Global Clean Energy ETF trades at $17.28 (market cap $2.27B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 6.3× iShares Global Clean Energy ETF's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and iShares Global Clean Energy ETF for 87 Days on average.
| CRL | ICLN | |
|---|---|---|
Market Cap | $14.23B | $2.27B |
Volume | 1,176,885 | 6,845,064 |
Sector | Health | — |
52-Week High | $310.77 | $23.75 |
52-Week Low | $149.93 | $15.78 |
Typical Hold Time | 33 Days | 87 Days |
Enterprise Value | $17.06B | — |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
ICLN trades at $17.12, down 1.1% today, with a bearish technical signal from moving averages and neutral oscillators. The ETF faces volatility compared to traditional energy peers, with a 57.2% maximum drawdown noted in recent analysis. Recent news highlights its 0.38% expense ratio and global clean energy exposure across 105 holdings.
Outlook remains mixed; clean energy benefits from geopolitical shifts boosting renewables demand, but high fees and underperformance versus fossil fuel ETFs pose risks. Investor sentiment is cautious amid sector rotation and competitive pressure from higher-yielding energy alternatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →